NCT04259008View on ClinicalTrials.gov

Safety of Manganese Restriction in Neonatal Parenteral Nutrition

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

July 22, 2021

Study Completion Date

July 22, 2021

Conditions
Infant, Newborn, Disease
Interventions
OTHER

Manganese omission

Participants randomized to the experimental intervention arm will not receive added manganese in their parenteral nutrition.

OTHER

"5 mCg/kg/day manganese from Multitrace-4 Neonatal."

"5 mCg/kg/day manganese from Multitrace-4 Neonatal."

Trial Locations (1)

92123

Sharp Mary Birch Hospital for Women and Newborns, San Diego

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

Sharp HealthCare

OTHER

NCT04259008 - Safety of Manganese Restriction in Neonatal Parenteral Nutrition | Biotech Hunter | Biotech Hunter